Search Results - "Schettler, Pamela J"

Adverse Consequences of Glucocorticoid Medication: Psychological, Cognitive, and Behavioral Effects by Judd, Lewis L., Schettler, Pamela J., Brown, E. Sherwood, Wolkowitz, Owen M., Sternberg, Esther M., Bender, Bruce G., Bulloch, Karen, Cidlowski, John A., Ronald de Kloet, E., Fardet, Laurence, Joëls, Marian, Leung, Donald Y.M., McEwen, Bruce S., Roozendaal, Benno, Van Rossum, Elisabeth F.C., Ahn, Junyoung, Brown, David W., Plitt, Aaron, Singh, Gagandeep

“…Glucocorticoids are the most commonly prescribed anti-inflammatory/immunosuppressant medications worldwide. This article highlights the risk of clinically…”
Get full text

A double-blind, randomized controlled clinical trial comparing eicosapentaenoic acid versus docosahexaenoic acid for depression by Mischoulon, David, Nierenberg, Andrew A, Schettler, Pamela J, Kinkead, Becky L, Fehling, Kiki, Martinson, Max A, Hyman Rapaport, Mark

“…To compare 2 omega-3 (n-3) preparations enriched with eicosapentaenoic acid (EPA) versus docosahexaenoic acid (DHA) as monotherapy for major depressive…”
Get full text

Psychosocial disability and work role function compared across the long-term course of bipolar I, bipolar II and unipolar major depressive disorders by Judd, Lewis L, Schettler, Pamela J, Solomon, David A, Maser, Jack D, Coryell, William, Endicott, Jean, Akiskal, Hagop S

“…Abstract Objective The research literature on psychosocial disability and work in mood disorders has either focused on relatively short-term course, or did not…”
Get full text

Six versus twelve weeks of Swedish massage therapy for generalized anxiety disorder: Preliminary findings by Rapaport, Mark Hyman, Schettler, Pamela J., Larson, Erika R., Dunlop, Boadie W., Rakofsky, Jeffrey J., Kinkead, Becky

“…Acute treatment of Generalized Anxiety Disorder often requires 3 months or more of care in order to optimize response. As part of an exploratory grant we have…”
Get full text

Individuals with depression exhibiting a pro-inflammatory phenotype receiving omega-3 polyunsaturated fatty acids experience improved motivation-related cognitive function: Preliminary results from a randomized controlled trial by Mac Giollabhui, Naoise, Mischoulon, David, Dunlop, Boadie W., Kinkead, Becky, Schettler, Pamela J., Liu, Richard T., Okereke, Olivia I., Lamon-Fava, Stefania, Fava, Maurizio, Rapaport, Mark Hyman

“…Cognitive impairment related to major depressive disorder (MDD) is highly prevalent, debilitating and is lacking in effective treatments; dysregulated…”
Get full text

Long-term symptomatic status of bipolar I vs. bipolar II disorders by Judd, Lewis L., Schettler, Pamela J., Akiskal, Hagop S., Maser, Jack, Coryell, William, Solomon, David, Endicott, Jean, Keller, Martin

“…Weekly affective symptom severity and polarity were compared in 135 bipolar I (BP I) and 71 bipolar II (BP II) patients during up to 20 yr of prospective…”
Get full text

The distinct temperament profiles of bipolar I, bipolar II and unipolar patients by Akiskal, Hagop S., Kilzieh, Nael, Maser, Jack D., Clayton, Paula J., Schettler, Pamela J., Traci Shea, M., Endicott, Jean, Scheftner, William, Hirschfeld, Robert M.A., Keller, Martin B.

“…Despite a plethora of studies, controversies abound on whether the long-term traits of unipolar and bipolar patients could be differentiated by temperament and…”
Get full text

Deficits in Psychological Well‐Being and Quality‐of‐Life in Minor Depression: Implications for DSM‐V by Nierenberg, Andrew A., Rapaport, Mark Hyman, Schettler, Pamela J., Howland, Robert H., Smith, Juliana A., Edwards, Deidre, Schneider, Trisha, Mischoulon, David

“…Objective: To examine deficits in psychological well‐being (PWB) and quality‐of‐life (QOL) in minor depressive disorder (Min D). Method: Ninety‐three subjects…”
Get full text

Overt irritability/anger in unipolar major depressive episodes: past and current characteristics and implications for long-term course by Judd, Lewis L, Schettler, Pamela J, Coryell, William, Akiskal, Hagop S, Fiedorowicz, Jess G

“…Although symptoms of irritability or anger are not central to the diagnosis of unipolar major depressive episodes (MDEs), these symptoms have been found, in…”
Get more information

Clinical response to EPA supplementation in patients with major depressive disorder is associated with higher plasma concentrations of pro-resolving lipid mediators by Lamon-Fava, Stefania, Liu, Minying, Dunlop, Boadie W, Kinkead, Becky, Schettler, Pamela J, Felger, Jennifer C, Ziegler, Thomas R, Fava, Maurizio, Mischoulon, David, Rapaport, Mark Hyman

“…Chronic inflammation has been implicated in the pathophysiology of major depressive disorder (MDD). Activating the resolution of inflammation through ω-3 fatty…”
Get full text

Dose- and time-dependent increase in circulating anti-inflammatory and pro-resolving lipid mediators following eicosapentaenoic acid supplementation in patients with major depressive disorder and chronic inflammation by Lamon-Fava, Stefania, So, Jisun, Mischoulon, David, Ziegler, Thomas R., Dunlop, Boadie W., Kinkead, Becky, Schettler, Pamela J., Nierenberg, Andrew A., Felger, Jennifer C., Maddipati, Krishna Rao, Fava, Maurizio, Rapaport, Mark Hyman

“…•EPA supplementation dose-dependently increases EPA-derived lipid mediators.•A daily dose of 4 g EPA is associated with increases in EPA-derived resolvin E2…”
Get full text

Massage therapy decreases cancer‐related fatigue: Results from a randomized early phase trial by Kinkead, Becky, Schettler, Pamela J., Larson, Erika R., Carroll, Dedric, Sharenko, Margaret, Nettles, James, Edwards, Sherry A., Miller, Andrew H., Torres, Mylin A., Dunlop, Boadie W., Rakofsky, Jeffrey J., Rapaport, Mark Hyman

“…BACKGROUND Cancer‐related fatigue (CRF) is a prevalent and debilitating symptom experienced by cancer survivors, yet treatment options for CRF are limited. In…”
Get full text

Omega-3 Fatty Acids for Major Depressive Disorder With High Inflammation: A Randomized Dose-Finding Clinical Trial by Mischoulon, David, Dunlop, Boadie W., Kinkead, Becky, Schettler, Pamela J., Lamon-Fava, Stefania, Rakofsky, Jeffrey J., Nierenberg, Andrew A., Clain, Alisabet J., Crowe, Tanja Mletzko, Wong, Andrea, Felger, Jennifer C., Sangermano, Lisa, Ziegler, Thomas R., Cusin, Cristina, Fisher, Lauren B., Fava, Maurizio, Rapaport, Mark Hyman

“…Objective: This study compared the impact of 3 eicosapentaenoic acid (EPA) doses versus placebo on inflammatory biomarkers and depressive symptoms. Methods:…”
Get full text

A Brief Clinical Tool to Estimate Individual Patients’ Risk of Depressive Relapse Following Remission: Proof of Concept by Judd, Lewis L, Schettler, Pamela J, Rush, A. John

“…Objective:The authors sought to determine whether symptoms experienced by formerly depressed patients after at least 8 weeks of remission can be used to…”
Get full text

Prevalence and clinical significance of subsyndromal manic symptoms, including irritability and psychomotor agitation, during bipolar major depressive episodes by Judd, Lewis L, Schettler, Pamela J, Akiskal, Hagop, Coryell, William, Fawcett, Jan, Fiedorowicz, Jess G, Solomon, David A, Keller, Martin B

“…Abstract Background There is increasing evidence that subsyndromal manic symptoms occur frequently during bipolar major depressive episodes (MDEs) and may be a…”
Get full text

A New Empirical Definition of Major Depressive Episode Recovery and Its Positive Impact on Future Course of Illness by Judd, Lewis L, Schettler, Pamela J, Rush, A John, Coryell, William H, Fiedorowicz, Jess G, Solomon, David A

“…To provide the first head-to-head test of the predictive validity of 2 resolution levels included in the current consensus definition of major depressive…”
Get full text

A preliminary descriptive report of the longevity of the effects of Swedish Massage therapy for subjects with Generalized Anxiety Disorder by Rapaport, Mark Hyman, Schettler, Pamela J., Larson, Erika R., Edwards, Sherry A., Dunlop, Boadie W., Rakofsky, Jeffrey J., Kinkead, Becky

“…Generalized Anxiety Disorder (GAD) is a prevalent and costly disorder, and many patients may prefer non-traditional treatment. A proof-of-concept study…”
Get full text

Anxiety and Outcome in Bipolar Disorder by Coryell, William, Solomon, David A., Fiedorowicz, Jess G., Endicott, Jean, Schettler, Pamela J., Judd, Lewis L.

“…Objective: Important differences exist between bipolar disorder with and without comorbid anxiety, but little is known about the long-term prognostic…”
Get full text

The treatment of minor depression with St. John’s Wort or citalopram: Failure to show benefit over placebo by Rapaport, Mark Hyman, Nierenberg, Andrew A, Howland, Robert, Dording, Christina, Schettler, Pamela J, Mischoulon, David

“…Abstract This paper presents new data addressing two important controversies in psychiatry: the construct of Minor Depression (MinD) and the efficacy of St…”
Get full text

The comparative clinical phenotype and long term longitudinal episode course of bipolar I and II: a clinical spectrum or distinct disorders? by Judd, Lewis L., Akiskal, Hagop S., Schettler, Pamela J., Coryell, William, Maser, Jack, Rice, John A., Solomon, David A., Keller, Martin B.

“…Background: The present analyses were designed to compare the clinical characteristics and long-term episode course of Bipolar-I and Bipolar-II patients in…”
Get full text